Literature DB >> 36229656

Surface-guided DIBH radiotherapy for left breast cancer: impact of different thresholds on intrafractional motion monitoring and DIBH stability.

A Gnerucci1, M Esposito2, A Ghirelli2, S Pini2, L Paoletti3, R Barca3, S Fondelli3, P Alpi3, B Grilli3, F Rossi4, S Scoccianti3, S Russo2.   

Abstract

PURPOSE: To compare two left breast cancer patient cohorts (tangential vs. locoregional deep-inspiration breath-hold - DIBH treatment) with different predefined beam gating thresholds and to evaluate their impact on motion management and DIBH stability.
METHODS: An SGRT-based clinical workflow was adopted for the DIBH treatment. Intrafractional monitoring was performed by tracking both the respiratory signal and the real-time displacement between the isocenter on the daily reference surface and on the live surface ("SGRT shift"). Beam gating tolerances were 5 mm/4 mm for the SGRT shifts and 5 mm/3 mm for the gating window amplitude for breast tangential and breast + lymph nodes locoregional treatments, respectively. A total of 24 patients, 12 treated with a tangential technique and 12 with a locoregional technique, were evaluated for a total number of 684 fractions. Statistical distributions of SGRT shift and respiratory signal for each treatment fraction, for each patient treatment, and for the two population samples were generated.
RESULTS: Lateral cumulative distributions of SGRT shifts for both locoregional and tangential samples were consistent with a null shift, whereas longitudinal and vertical ones were slightly negative (mean values < 1 mm). The distribution of the percentage of beam on time with SGRT shift > 3 mm, > 4 mm, or > 5 mm was extended toward higher values for the tangential sample than for the locoregional sample. The variability in the DIBH respiration signal was significantly greater for the tangential sample.
CONCLUSION: Different beam gating thresholds for surface-guided DIBH treatment of left breast cancer can impact motion management and DIBH stability by reducing the frequency of the maximum SGRT shift and increasing respiration signal stability when tighter thresholds are adopted.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Beam gating threshold; Deep-inspiration breath-hold; Intrafractional residual shift; Respiration signal stability; Surface-guided radiotherapy

Year:  2022        PMID: 36229656     DOI: 10.1007/s00066-022-02008-y

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   4.033


  31 in total

1.  Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer.

Authors:  Stine S Korreman; Anders N Pedersen; Lasse Rye Aarup; Trine J Nøttrup; Lena Specht; Håkan Nyström
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-06-05       Impact factor: 7.038

2.  Hybrid IMRT plans--concurrently treating conventional and IMRT beams for improved breast irradiation and reduced planning time.

Authors:  Charles S Mayo; Marcia M Urie; Thomas J Fitzgerald
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-01       Impact factor: 7.038

3.  Heart dose reduction by prone deep inspiration breath hold in left-sided breast irradiation.

Authors:  Thomas Mulliez; Liv Veldeman; Bruno Speleers; Khalil Mahjoubi; Vincent Remouchamps; Annick Van Greveling; Monique Gilsoul; Dieter Berwouts; Yolande Lievens; Rudy Van den Broecke; Wilfried De Neve
Journal:  Radiother Oncol       Date:  2014-12-09       Impact factor: 6.280

4.  Stereotactic/hypofractionated body radiation therapy as an effective treatment for lymph node metastases from colorectal cancer: an institutional retrospective analysis.

Authors:  Ciro Franzese; Antonella Fogliata; Tiziana Comito; Angelo Tozzi; Cristina Iftode; Elena Clerici; Davide Franceschini; Pierina Navarria; Anna Maria Ascolese; Lucia Di Brina; Fiorenza De Rose; Giuseppe R D'Agostino; Luca Cozzi; Marta Scorsetti
Journal:  Br J Radiol       Date:  2017-10-03       Impact factor: 3.039

5.  Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue.

Authors:  Silvia C Formenti; Daniela Gidea-Addeo; Judith D Goldberg; Daniel F Roses; Amber Guth; Barry S Rosenstein; Keith J DeWyngaert
Journal:  J Clin Oncol       Date:  2007-04-30       Impact factor: 44.544

6.  Risk of ischemic heart disease in women after radiotherapy for breast cancer.

Authors:  Sarah C Darby; Marianne Ewertz; Paul McGale; Anna M Bennet; Ulla Blom-Goldman; Dorthe Brønnum; Candace Correa; David Cutter; Giovanna Gagliardi; Bruna Gigante; Maj-Britt Jensen; Andrew Nisbet; Richard Peto; Kazem Rahimi; Carolyn Taylor; Per Hall
Journal:  N Engl J Med       Date:  2013-03-14       Impact factor: 91.245

7.  Initial clinical experience with moderate deep-inspiration breath hold using an active breathing control device in the treatment of patients with left-sided breast cancer using external beam radiation therapy.

Authors:  Vincent M Remouchamps; Nicola Letts; Frank A Vicini; Michael B Sharpe; Larry L Kestin; Peter Y Chen; Alvaro A Martinez; John W Wong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-07-01       Impact factor: 7.038

Review 8.  Vaccines for preventing infection with Pseudomonas aeruginosa in cystic fibrosis..

Authors:  Helle Krogh Johansen; Peter C Gøtzsche
Journal:  Cochrane Database Syst Rev       Date:  2013-06-17

9.  Breathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold.

Authors:  Anders N Pedersen; Stine Korreman; Håkan Nyström; Lena Specht
Journal:  Radiother Oncol       Date:  2004-07       Impact factor: 6.280

10.  A comparative dosimetric study for treating left-sided breast cancer for small breast size using five different radiotherapy techniques: conventional tangential field, filed-in-filed, tangential-IMRT, multi-beam IMRT and VMAT.

Authors:  Guang-Hua Jin; Li-Xin Chen; Xiao-Wu Deng; Xiao-Wei Liu; Ying Huang; Xiao-Bo Huang
Journal:  Radiat Oncol       Date:  2013-04-15       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.